{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:10:27Z","timestamp":1789506627431,"version":"build-2803163510"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UKRI Future Leaders Fellowship","award":["MR\/S017151\/1"],"award-info":[{"award-number":["MR\/S017151\/1"]}]},{"name":"MRC Centre for Reproductive Health"},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018645","name":"MRC","doi-asserted-by":"publisher","award":["MR\/N022556\/1"],"award-info":[{"award-number":["MR\/N022556\/1"]}],"id":[{"id":"10.13039\/100018645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Increasing childhood cancer survival rates in recent decades have led to an increased focus on fertility as a long-term complication of cancer treatment. Male childhood cancer survivors often face compromised testicular function as a late effect of chemotherapy exposure, with no well-established options to prevent such damage and subsequent infertility. Despite vincristine being considered to be associated with low-gonadotoxic potential, in prepubertal rodents, it was recently shown to result in morphological alterations of the testis and in severely impaired fertility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVE AND RATIONALE<\/jats:title>\n                  <jats:p>This systematic review aimed to evaluate the effects of vincristine-containing regimens on human prepubertal testis with reference to testicular function and fertility in adulthood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SEARCH METHODS<\/jats:title>\n                  <jats:p>The systematic search of the literature was conducted according to PRISMA guidelines, and the study was registered with PROSPERO. PubMed and Scopus were searched for articles published in English between 01 January 1900 and 05 March 2021, with the search including \u2018chemotherapy\u2019, \u2018vincristine\u2019, \u2018prepubertal\u2019, \u2018testis\u2019, \u2018spermatogenesis\u2019 and related terms. Abstracts and full-text articles were screened and selected for, providing they met the inclusion criteria (\u226412\u2009years at treatment, exposure to vincristine-containing regimens and long-term fertility outcomes). Additional studies were identified via bibliography screening. Bias evaluation across included studies was conducted using the ROBINS-I tool, subdivided into assessment for confounding, participant selection, intervention classification, missing data, outcome measurements and selection of reported results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OUTCOMES<\/jats:title>\n                  <jats:p>Our initial search identified 288 articles of which 24 (8%; n\u2009=\u20097134 males) met all inclusion criteria. Control groups were included for 9\/24 (38%) studies and 4\/24 (17%) studies provided sub-analysis of the relative gonadotoxicity of vincristine-based agents. Primary outcome measures were: fertility and parenthood; semen analysis (World Health Organization criteria); and hormonal function and testicular volume. For the studies that performed vincristine sub-analysis, none reported negative associations with vincristine for the potential of siring a pregnancy, including the largest (n\u2009=\u20096224; hazard ratio\u2009=\u20090.56) controlled study. For semen analysis, no significant difference versus healthy controls was illustrated for mitotic inhibitors (including vincristine) following sub-analysis in one study (n\u2009=\u2009143). For hormone analysis, a single study did not find significant impacts on spermatogenesis attributed to vincristine based on levels of FSH and semen analysis, which meant that its administration was unlikely to be responsible for the diminished testicular reserve; however, most of the studies were based on low numbers of patients receiving vincristine-containing chemotherapy. Analysis of bias demonstrated that studies which included vincristine exposure sub-analysis had a lower risk of bias when compared with cohorts which did not.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS<\/jats:title>\n                  <jats:p>In contrast to recent findings in rodent studies, the limited number of clinical studies do not indicate gonadotoxic effects of vincristine following prepubertal exposure. However, given the relative lack of data from studies with vincristine sub-analysis, experimental studies involving vincristine exposure using human testicular tissues are warranted. Results from such studies could better inform paediatric cancer patients about their future fertility and eligibility for fertility preservation before initiation of treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humupd\/dmac039","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T19:34:56Z","timestamp":1670700896000},"page":"233-245","source":"Crossref","is-referenced-by-count":18,"title":["The impact of vincristine on testicular development and function in childhood cancer"],"prefix":"10.1093","volume":"29","author":[{"given":"Ioanna","family":"Clark","sequence":"first","affiliation":[{"name":"MRC Centre for Reproductive Health, The Queen\u2019s Medical Research Institute, The University of Edinburgh , Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F H","family":"Brougham","sequence":"additional","affiliation":[{"name":"Department of Paediatric Oncology, Royal Hospital for Children and Young People , Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-1974","authenticated-orcid":false,"given":"Norah","family":"Spears","sequence":"additional","affiliation":[{"name":"Edinburgh Medical School: Biomedical Sciences, Hugh Robson Building , Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4650-3765","authenticated-orcid":false,"given":"Rod T","family":"Mitchell","sequence":"additional","affiliation":[{"name":"MRC Centre for Reproductive Health, The Queen\u2019s Medical Research Institute, The University of Edinburgh , Edinburgh, UK"},{"name":"Department of Paediatric Endocrinology, Royal Hospital for Children and Young People , Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,10]]},"reference":[{"key":"2023051109504077700_dmac039-B1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3476(83)80584-8","article-title":"Primary gonadal damage following treatment of brain tumors in childhood","volume":"103","author":"Ahmed","year":"1983","journal-title":"J Pediatr"},{"key":"2023051109504077700_dmac039-B2","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/annonc\/mdi401","article-title":"Successful ambulatory treatment of Hodgkin\u2019s disease in Iranian children based on German-Austrian DAL-HD 85-90: single institutional results","volume":"16","author":"Alebouyeh","year":"2005","journal-title":"Ann Oncol"},{"key":"2023051109504077700_dmac039-B3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ar.1092090409","article-title":"Responsiveness of testis morphology to chemotherapy in childhood leukemia","volume":"209","author":"Anelli","year":"1984","journal-title":"Anat Rec"},{"key":"2023051109504077700_dmac039-B4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/humrep\/deaa057","article-title":"A multi-organ-chip co-culture of liver and testis equivalents: a first step toward a systemic male reprotoxicity model","volume":"35","author":"Baert","year":"2020","journal-title":"Hum Reprod"},{"key":"2023051109504077700_dmac039-B5","doi-asserted-by":"crossref","first-page":"e0226262","DOI":"10.1371\/journal.pone.0226262","article-title":"Sperm DNA integrity in adult survivors of paediatric leukemia and lymphoma: a pilot study on the impact of age and type of treatment","volume":"14","author":"Beaud","year":"2019","journal-title":"PLoS One"},{"key":"2023051109504077700_dmac039-B6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/REP-17-0005","article-title":"Doxorubicin and vincristine affect undifferentiated rat spermatogonia","volume":"153","author":"Beaud","year":"2017","journal-title":"Reproduction"},{"key":"2023051109504077700_dmac039-B7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/088800100276415","article-title":"Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma","volume":"17","author":"Ben Arush","year":"2000","journal-title":"Pediatr Hematol Oncol"},{"key":"2023051109504077700_dmac039-B8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1470-2045(16)00086-3","article-title":"Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort","volume":"17","author":"Chow","year":"2016","journal-title":"Lancet Oncol"},{"key":"2023051109504077700_dmac039-B9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.mpmed.2011.09.012","article-title":"Cytotoxic chemotherapy: clinical aspects","volume":"39","author":"Corrie","year":"2011","journal-title":"Medicine"},{"key":"2023051109504077700_dmac039-B10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1200\/JCO.1985.3.11.1495","article-title":"Hodgkin\u2019s disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB","volume":"3","author":"Cramer","year":"1985","journal-title":"J Clin Oncol"},{"key":"2023051109504077700_dmac039-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-74862-8","article-title":"Paradoxical risk of reduced fertility after exposure of prepubertal mice to vincristine or cyclophosphamide at low gonadotoxic doses in humans","volume":"10","author":"Delessard","year":"2020","journal-title":"Sci Rep"},{"key":"2023051109504077700_dmac039-B12","first-page":"306","article-title":"Gonadal function in prepubertal boys following treatment for Hodgkin\u2019s disease","volume":"15","author":"Dhabhar","year":"1993","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"2023051109504077700_dmac039-B13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/humupd\/dmy015","article-title":"The risk of TESE-induced hypogonadism: a systematic review and meta-analysis","volume":"24","author":"Eliveld","year":"2018","journal-title":"Hum Reprod Update"},{"key":"2023051109504077700_dmac039-B14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.reprotox.2006.04.020","article-title":"Progress in the development of childhood cancer therapy","volume":"22","author":"Garolla","year":"2006","journal-title":"Reprod Toxicol"},{"key":"2023051109504077700_dmac039-B15","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1097-0142(19891201)64:11<2335::AID-CNCR2820641124>3.0.CO;2-7","article-title":"Pregnancy outcome after treatment for acute lymphoblastic leukemia during childhood or adolescence","volume":"64","author":"Green","year":"1989","journal-title":"Cancer"},{"key":"2023051109504077700_dmac039-B16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2009.24.9037","article-title":"Fertility of male survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"28","author":"Green","year":"2010","journal-title":"J Clin Oncol"},{"key":"2023051109504077700_dmac039-B17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2023051109504077700_dmac039-B18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pbc.23363","article-title":"Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study","volume":"59","author":"Hamre","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"2023051109504077700_dmac039-B19","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<2020::AID-CNCR25>3.0.CO;2-Y","article-title":"Irreversible gonadal damage in male survivors of pediatric Hodgkin\u2019s disease","volume":"78","author":"Heikens","year":"1996","journal-title":"Cancer"},{"key":"2023051109504077700_dmac039-B20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/pbc.20172","article-title":"Fertility in males treated for Hodgkins disease with COPP\/ABV hybrid","volume":"44","author":"Hobbie","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"2023051109504077700_dmac039-B21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mpo.2950160404","article-title":"Male reproductive function in long-term survivors of childhood cancer","volume":"16","author":"Jaffe","year":"1988","journal-title":"Med Pediatr Oncol"},{"key":"2023051109504077700_dmac039-B22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2023051109504077700_dmac039-B23","doi-asserted-by":"crossref","first-page":"e0181377","DOI":"10.1371\/journal.pone.0181377","article-title":"Follicle stimulating hormone is an accurate predictor of azoospermia in childhood cancer survivors","volume":"12","author":"Kelsey","year":"2017","journal-title":"PLoS One"},{"key":"2023051109504077700_dmac039-B24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/1097-0142(20010201)91:3<613::AID-CNCR1042>3.0.CO;2-R","article-title":"High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood","volume":"91","author":"Kenney","year":"2001","journal-title":"Cancer"},{"key":"2023051109504077700_dmac039-B25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/08880010902973665","article-title":"Testicular function after treatment for acute lymphoblastic leukemia (all) in prepubertal and pubertal boys","volume":"26","author":"Krawczuk-Rybak","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"key":"2023051109504077700_dmac039-B26","doi-asserted-by":"crossref","first-page":"e13853","DOI":"10.1111\/and.13853","article-title":"Semen analysis and treatment risk factors in long-term survivors of childhood cancer","volume":"53","author":"Kruseov\u00e1","year":"2021","journal-title":"Andrologia"},{"key":"2023051109504077700_dmac039-B27","first-page":"3575","article-title":"Cytotoxic effects of chemotherapeutic drugs on mouse testis cells","volume":"39","author":"Lu","year":"1979","journal-title":"Cancer Research"},{"key":"2023051109504077700_dmac039-B28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s43032-020-00357-6","article-title":"Histologic analysis of testes from prepubertal patients treated with chemotherapy associates impaired germ cell counts with cumulative doses of cyclophosphamide, ifosfamide, cytarabine, and asparaginase","volume":"28","author":"Medrano","year":"2021","journal-title":"Reprod Sci"},{"key":"2023051109504077700_dmac039-B29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2023051109504077700_dmac039-B30","doi-asserted-by":"crossref","first-page":"j495","DOI":"10.1136\/bmj.j495","article-title":"Fertility preservation: don\u2019t forget the boys","volume":"356","author":"Mitchell","year":"2017","journal-title":"BMJ"},{"key":"2023051109504077700_dmac039-B31","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2023051109504077700_dmac039-B32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/BF02002903","article-title":"Gonadal function of young adults after therapy of malignancies during childhood or adolescence","volume":"155","author":"M\u00fcller","year":"1996","journal-title":"Eur J Pediatr"},{"key":"2023051109504077700_dmac039-B33","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/jc.2009-0060","article-title":"Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility","volume":"94","author":"Nurmio","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2023051109504077700_dmac039-B34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0360-3016(90)90007-7","article-title":"Gonadal status and reproductive function following treatment for Hodgkin\u2019s disease in childhood: the Stanford experience","volume":"19","author":"Ortin","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023051109504077700_dmac039-B36","first-page":"1690","article-title":"Gonadal function and fertility in male survivors treated for Hodgkin\u2019s disease in Iran","volume":"28","author":"Rafsanjani","year":"2007","journal-title":"Saudi Med J"},{"key":"2023051109504077700_dmac039-B37","first-page":"991","article-title":"Histology and histopathology from cell biology to tissue engineering the prepubertal testis: a quiescent or a silently active organ?","volume":"14","author":"Rey","year":"1999","journal-title":"Histol Histopathol"},{"key":"2023051109504077700_dmac039-B38","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.1988.03720140043031","article-title":"The relationship of gonadal activity and chemotherapy-induced gonadal damage","volume":"259","author":"Rivkees","year":"1988","journal-title":"JAMA"},{"key":"2023051109504077700_dmac039-B39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.urology.2013.08.043","article-title":"Microdissection testicular sperm extraction and salvage hormonal treatment in patients with postchemotherapy azoospermia","volume":"83","author":"Shiraishi","year":"2014","journal-title":"Urology"},{"key":"2023051109504077700_dmac039-B40","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2023051109504077700_dmac039-B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01844-y","article-title":"Cisplatin and carboplatin result in similar gonadotoxicity in immature human testis with implications for fertility preservation in childhood cancer","volume":"18","author":"Tharmalingam","year":"2020","journal-title":"BMC Med"},{"key":"2023051109504077700_dmac039-B42","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humupd\/dmaa041","article-title":"Impacts of platinum-based chemotherapy on subsequent testicular function and fertility in boys with cancer","volume":"26","author":"Tian En","year":"2020","journal-title":"Hum Reprod Update"},{"key":"2023051109504077700_dmac039-B43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fendo.2019.00555","article-title":"Gonadal failure is common in long-term survivors of childhood high-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell rescue","volume":"10","author":"Utriainen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023051109504077700_dmac039-B44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/humupd\/dmp054","article-title":"Options for fertility preservation in prepubertal boys","volume":"16","author":"Wyns","year":"2010","journal-title":"Hum Reprod Update"},{"key":"2023051109504077700_dmac039-B45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2478\/v10019-010-0034-8","article-title":"Gonadal function in patients treated for Hodgkin\u2019s disease in childhood","volume":"44","author":"Zaletel","year":"2010","journal-title":"Radiol Oncol"},{"key":"2023051109504077700_dmac039-B46","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pon.784","article-title":"Fertility issues for young adult survivors of childhood cancer","volume":"13","author":"Zebrack","year":"2004","journal-title":"Psychooncology"},{"key":"2023051109504077700_dmac039-B47","year":"2021"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/29\/2\/233\/50276299\/dmac039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/29\/2\/233\/50276299\/dmac039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T09:52:48Z","timestamp":1683798768000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/29\/2\/233\/6887252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,12,10]]},"published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmac039","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2022,12,10]]}}}